Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ACIU compared with ENTX: revenue, margins and what each company keeps, and the suppliers and customers both name
ACIU
AC Immune SA
Change
Mkt cap
Revenue
Revenue
ENTX
Entera Bio Ltd.
Change
Mkt cap
Revenue
Revenue
vs
Compare
ACIU
AC Immune SA
vs
ENTX
Entera Bio Ltd.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only ACIU
4
LLY
Eli Lilly
customer
JNJ
Janssen Pharmaceuticals
customer
LNTH
Lantheus
customer
TAK
Takeda Pharmaceuticals USA
customer
Shared
0
No shared counterparties.
Only ENTX
1
OPK
OPKO Health
supplier
Role chip = supplier or customer
Source: SEC EDGAR
ACIU
AC Immune SA
Change
2.08
· pre 2.08
· delayed
Mkt cap
$211.9M
Revenue
—
ENTX
Entera Bio Ltd.
Change
3.00
· pre 3.00
· delayed
Pre-market
Nov 5 '26
delayed
Mkt cap
$150.8M
Revenue
$42,000
Q1 FY25
vs
Compare
Pre-market
Nov 5 '26
delayed
ACIU
AC Immune SA
vs
ENTX
Entera Bio Ltd.
2.08
pre 2.08
delayed
Price
3.00
pre 3.00
delayed
$211.9M
Mkt cap
$150.8M
—
Revenue
$42,000
Q1 FY25
Change
Change
ACIU
2.08
vs
ENTX
3.00
Pre-market
Nov 5 '26
delayed